alzheimer disease can we prevent it?
DESCRIPTION
ALZHEIMER DISEASE Can we prevent it?. Kamal KALLAB MD Arab Conference on Alzheimer Disease March 2-4, 2005 Beirut. ALZHEIMER DISEASE Can we prevent it?. Two main reasons: Alzheimer Disease (AD) Is a public health problem worldwide - PowerPoint PPT PresentationTRANSCRIPT
march,03,2005 1
ALZHEIMER DISEASECan we prevent it?
Kamal KALLAB MDArab Conference on Alzheimer DiseaseMarch 2-4, 2005
Beirut
march,03,2005 2
ALZHEIMER DISEASE Can we prevent it?
Two main reasons: Alzheimer Disease (AD) Is a public
health problem worldwide AD is a source of fear especially in
individuals who have a family history
march,03,2005 3
ALZHEIMER DISEASE Can we prevent it?
Two main difficulties: Follow-up length Multiple variants to adjust
march,03,2005 4
ALZHEIMER DISEASE Can we prevent it?
Introductory remarks: Prevention from AD must be a part of
a comprehensive concept of Dementia (Frequency of mixed dementia)
Prevention from AD must be a part of a comprehensive strategy of management of AD
march,03,2005 5
ALZHEIMER DISEASE Can we prevent it?
Comprehensive concept of Dementia: Similarities with a treasure or a bank account
Built up period ( learning) Stabilization Progressive loss
Use Regular devaluation (Normal aging?) Rapid devaluation ( Degenerative?) Bad management ( non healthy life?)
More acute phenomena: Bankrupt, Stock market crash ( Stroke, trauma,
infections,..)
march,03,2005 6
ALZHEIMER DISEASE Can we prevent it?
In case of AD, the mental status at a given time, is the result of AD lesions and possible other pathologic processes. Some are preventable or treatable
march,03,2005 7
ALZHEIMER DISEASE Can we prevent it?
Normal aging
ADTrauma
Stroke
infection
march,03,2005 8
ALZHEIMER DISEASE Can we prevent it?
Theses pathologic processes are: Stroke: Second cause of dementia Infections Trauma Toxic substances and drugs Metabolic disorders Other associated degenerative
diseases
march,03,2005 9
ALZHEIMER DISEASE Can we prevent it? Comprehensive strategy in the management of
AD Prevention
Slowing (or stopping) disease course
Substitution of chemical deficit / Inhibition of excitotoxicity
Relieve other symptoms
Better use of remaining skills
march,03,2005 10
ALZHEIMER DISEASE Can we prevent it? Prevention Slowing ( or stopping) disease course
Vaccination Secretase inhibition? Anti-NMDA? GinkoBiloba? Idebenone Neurotrophic factors,..
Substitution of chemical deficit / Inhibition of excitotoxicity Cholinesterase inhib. Anti-NMDA
Relieve other symptoms : Non pharmacological measures antidepressants, antipsychotics, anxiolytics, ..
Better use of remaining skills : Environnement (emotional, psychological, familial, institutional,…) Other medical problems Speech therapy, occupationnal therapy,..
march,03,2005 11
ALZHEIMER DISEASE Can we prevent it?
Prevention from AD: State of the art In contrast with the disease prevalence,
few amount of valid data Randomized studies can be easily
biaised Reliability of questionnaire in case of
memory disturbances Multiple factors- statistical analysis pitfalls
march,03,2005 12
ALZHEIMER DISEASE Can we prevent it?
Numerous possible preventive factors were studied.
Except for Hormone Replacement Therapy (HRT), No large scale randomized primary prevention trials completed
march,03,2005 13
ALZHEIMER DISEASE Can we prevent it?
HRT: Kawas, Neurology 1997: 472 peri or post-
menopausal women, 16 years. Relative risk 0.46 Tang, Lancet 1996: meopausal 156 ORT/1124 RR 0.4 Shumaker, JAMA 2003 (WHI study): 4532
postmenopausal women, > 65, HRT group 2229, conjugated equine estrogen+medroxyprogesterone. 40 of HRT group developped AD versus 21 in control group RR 2.05
march,03,2005 14
ALZHEIMER DISEASE Can we prevent it? HRT: Conclusions
Lesson of Humility Symptomatic action on cognition? What about different types of drugs? Role of early medication onset age?
(Henderson, Neurol Neurosurg Psychiatry. 2005) Risk-benefit: HRT is no more recommended
for AD prevention, unless future data….
march,03,2005 15
ALZHEIMER DISEASE Can we prevent it?
Non Steroidal Antiinflammatory Drugs (NSAIDs) Epidemiologic studies:
Broe, Arch. Neurol, 2000 - / Beard, Mayo clinic process, 1998 +/ Rotterdam study, 1998+?/ Stewart, neurology, 1997+,..
In’t Veld & all,NSAID on risk of AD, N Engl J Med, 2001
Metaanalysis Ongoing: http://www.2stopAD.org ( Randomized
control trial)
march,03,2005 16
ALZHEIMER DISEASE Can we prevent it? NSAIDs
In’t Veld & all,NSAID on risk of AD, N Engl J Med, 2001
6989, >55, Average FU 6.8 years computerized pharmacy records 394 dementia, 293 AD RR according to duration:
< 1month: 0.95 1-24 m: 0.83 > 24 months cumulative use: 0.20
Critical period during wich NSAID use is protective?
march,03,2005 17
ALZHEIMER DISEASE Can we prevent it?
NSAIDs Metaanalysis: Etminan BMJ 2003: 9 all
NSAID >55, ( 6 cohort 13211 pts, 3 case control 1443 pts)
Pooled RR: 0.72 According to duration:
Short 0.95 Intermediate 0.83 Long-term 0.27
Pooled RR among Aspirin users 0.87 ( 0.7-1.07)
march,03,2005 18
ALZHEIMER DISEASE Can we prevent it? NSAIDs:
Effect on cognitive function: Hee Kang, Neurology 2003:
13255 women, tests administered by telephone RR0.75 aspirin +15y, RR 0.79 NSAID ( mainly Ibuprofen) +8 y. For global cognitive decline, nonaspirine agents shoed lower RR ( 0.93 vs 0.77)
Protection from Parkinson disease: Chen, Arch Neurol 2003:
44057 men, 98845 women Nonaspirin NSAID: Pooled RR regular users vs non regular
users 0.55 Aspirin: Non significant difference
march,03,2005 19
ALZHEIMER DISEASE Can we prevent it? NSAIDs
Mechanism of action: Cultured cells: Ibuprofen, Indomethacin and Sulindac
lowered the production of the highly amyloidogenic Abeta42 peptide by as much as 80%
Mouse models: Similar effects with Ibuprofen on Abeta42
Alteration of gamma secretase activity This effect was not seen with all NSAIDs Independent of cyclooxygenase inhibition Protective NSAID mark: inhibit GTP-binding protein
Rho?
march,03,2005 20
ALZHEIMER DISEASE Can we prevent it?
NSAIDs conclusions: Low dose nonaspirin NSAID, especially
Ibuprofen 200 mg/d, have to be considered as possible preventive tool from AD.
Benefit Risk golden rule High Risk group ( strong family history ) ?
march,03,2005 21
ALZHEIMER DISEASE Can we prevent it? Statins:
Epidemiologic Studies: Wolozin, Arch Neurol, 2000:
Prevalence of AD in the groupe taking statins (lovastatin or pravastatin) was 60 to 70% (p<0.001) lower than the total patient population and patients taking other medications typically used in the treatment of Hypertension or cardiovascular disease.
Jick, Lancet 2000: 284 AD, 1080 Control RR ror statin users 0.2 VS 1 for non treated or treated with
non statins Zandi, Arch Gen Psychiatry. 2005:
“we found no association between statin use and subsequent onset of dementia or AD. Further research is warranted before costly dementia prevention trials with statins are undertaken”.
march,03,2005 22
ALZHEIMER DISEASE Can we prevent it?
Statins: Mechanisms of action:
Direct association between amyloid processing and cholesterol in the brain: Combined in vitro and guinea pig study found that simvastatin and lovastatin reduced intra and extracellular levels of amyloid peptides Abeta40 and 42
Decreasing the risk of stroke
march,03,2005 23
ALZHEIMER DISEASE Can we prevent it?
Antihypertensive therapy Epidemiological studies:
Rigaud, J Hum Hypertens, 2000 Birkenhager, Arch Intern Med, 2001 Forette, Arch Intern Med, 2002: (syst-euro
study) >60 y, SBP 160 to 219, non dementia at
randomization nitrendipine elanapril hydrochlorothiazide reduction of risk of dementia 55% including AD
Tzourio, Arch Intern Med, 2003
march,03,2005 24
ALZHEIMER DISEASE Can we prevent it?
Antihypertensive therapy Conflicting data
Length of follow-up Type of antihypertensive therapy used Frequent association of AD and Vascular dementia
In a comprehensive management of Dementia, HT should be treated actively
If further data will suggest clear advantage of one drug over other, then it will at least be a reason to choose it for HT treatment.
march,03,2005 25
ALZHEIMER DISEASE Can we prevent it? Antioxidants:
Theoretical Background AD lesions = Free radical exposure associated
lesions ( Bell 1997, Christen 2000) Exogenous antioxydants reduce the toxicity of
beta-amyloid in in-vitro studies of patients with AD ( Bell 1997, Christen 2000)
AD brain contains elevated levels of endogenous antioxydants (Morris 1998)
Controlled trial of selegiline and/or alphatocopherol suggested an efficacy in slowing disease progress ( Sano, N Engl J Med, 1977)
march,03,2005 26
ALZHEIMER DISEASE Can we prevent it?
Antioxidants: Epidemiological studies:
Several observational studies Two large prospective cohort studies
Engelhart JAMA 2002 Morris JAMA 2002
march,03,2005 27
ALZHEIMER DISEASE Can we prevent it? Antioxidants:
Engelhart JAMA 2002: 5395 pts, >55, 6 y FU, 197 developped dementia, of
whom 146 AD, Vitamine E intake from food adustements for multiple variables made: Age,
sexe, baseline MMS, alcohol intake, education, smoking, BMI, carotid plaque and antioxydant supplements
High intake ( >15.5mg/d) group was found 43% less likely to develop AD than low intake (<10.5mg/d)
This effect was more pronounced for smokers Vitamine C intake has a positive effect
march,03,2005 28
ALZHEIMER DISEASE Can we prevent it?
Antioxidants: Morris JAMA 2002
815 men, =/>65, 3.9 y FU, Vit E intake from food Adjustement for age, education, sexe, race,
ApoEepsilon 4 and FU length People with High intake (>10.4IU/d) were
70% less likely to be diagnosed with AD than the lowest intaket group ( <7.0IU/d)
ApoE epsilon 4 negative Pts showed significant protection
Antioxydant supplements ineffective
march,03,2005 29
ALZHEIMER DISEASE Can we prevent it?
Antioxidants: Limitation of these studies
Duration of FU Food frequency questionnaire with possible
cognitive dysfunction ( responses require sustained motivation, attention and memory)
Why only Antioxidants intake from food ( not supplements) affected outcomes??
march,03,2005 30
ALZHEIMER DISEASE Can we prevent it?
Antioxydants: Since the risk of vitamin E
supplementation is small it may be appropriate to consider 400-800 IU/d in case of strong family history
march,03,2005 31
ALZHEIMER DISEASE Can we prevent it? Diet
Consumption of fish and n-3 fatty acids: Morris, Arch Neurol 2003:
Obsevational study, 815 people, 65-94y. high intake of fish(once or more weekly) had RR
0.4 compared to rarely or never ate fish (9.5% absolute reduction)
Methodological pitfalls: adjustement for ather variants
Panza, Public Health Nutr. 2004 Mediterranean diet and cognitive decline, literature review
“Essential components of the Mediterranean diet--MUFA, cereals and wine--seem to be protective against cognitive decline”
march,03,2005 32
ALZHEIMER DISEASE Can we prevent it?
Alcohol Light to moderate drinking may be
protective Alcoholism is associated with
cognitive dysfunction
march,03,2005 33
ALZHEIMER DISEASE Can we prevent it?
Physical Activity Brnes, J Am Geriatr Soc, 2003:
Observational study, 349 people, 55 or older, 6 y FU
Higher level of cardiorespiratory fitness at baseline were associated with better preservation of cognitive function
Verghese, N Engl J Med, 2003: Observational study, 469 subjects, =/>75y, 5.1y FU
No relationship between physical activity and risk of dementia
march,03,2005 34
ALZHEIMER DISEASE Can we prevent it?
Cognitive activity Verghese, N Engl J Med, 2003:
Observational study, 469 subjects, =/>75y, 5.1y FU
Reading, playing board games and playing musical instruments, dancing were associated with reduced risk of dementia
Association with the cognitive-activity score persisted after exclusion of subjects with possible preclinical dementia at baseline
Results were similar for AD and Vascular demantia
march,03,2005 35
ALZHEIMER DISEASE Can we prevent it?
Cognitive activity: Critics
Given the same degree of AD pathology, people with better baseline cognitive reserve may still have enough skills to prevent the diagnosis of dementia
march,03,2005 36
ALZHEIMER DISEASE Can we prevent it? CONCLUSION:
Possible benefit: NSAIDs low doses, long term exposure Statins Vitamine E Fish Cognitive activity Physical activity?
Lessons from HRT In the absence of definite approval, use of drugs
must take in consideration the risk of developping AD vs the risk of medication
Prevention of cognitive decline must include other causes of dementia
march,03,2005 37
Byblos ByblosByblos